Is Perspective Therapeutics, stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Perspective Therapeutics, 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was $3.14, you would have made a profit of $12.12 per share or 385.99%
Yes, the average daily trading liquidity for Perspective Therapeutics, is $898 817 thousand. You should therefore be able to get in and out of your positions relatively fast.
Perspective Therapeutics, has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Perspective Therapeutics, to be medium [0.7 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.